CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-190

The recent price action has definitely been strange, but after all the news we have received recently (very strong sales growth and very positive reimbursement news to name a couple) and at such a low valuation, it's pretty easy to sit comfortably here and wait for the market to do its thing. The sales are only moving higher, and fast, and it's quite clear that they will soon be very profitable. Plenty of cash, no debt. A long runway for future growth as well with an abundance of additional expansion opportunities. A clear market leading device with a very strong and sturdy moat. Experienced long-term management team. Ticks plenty of boxes imo. Hopefully the price will explode into dollars soon enough, but this is certainly not a stressful stock to hold through the swings (perhaps frustrating though).